Difficulty: Medium
Average Score: 69%
Practice
Which antihypertensive would be appropriate to prescribe for a hypertensive patient (B/P 150/95) in her third trimester?
Correct answer
C
Rationale
In the scenario presented, the most appropriate antihypertensive to prescribe for a hypertensive pregnant patient in her third trimester with a blood pressure of 150/95 would be option C) Methyldopa. Methyldopa is commonly recommended for the treatment of hypertension in pregnancy due to its safety profile for both the mother and the fetus. It is considered a first-line therapy for managing hypertension during pregnancy because it has been extensively studied and shown to be effective in reducing blood pressure without adversely affecting the developing fetus.
Option A) Candesartan and option B) Lisinopril are contraindicated in pregnancy as they belong to the category of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), which are known to cause harm to the developing fetus, especially in the second and third trimesters. These medications can lead to fetal renal impairment, hypotension, skull hypoplasia, and even death.
Option D) Furosemide is a diuretic commonly used to treat hypertension, but it is not the first-line choice for managing hypertension in pregnancy. Diuretics like furosemide can cause electrolyte imbalances and reduce placental perfusion, potentially harming the fetus.
In an educational context, it is crucial for healthcare providers to have a thorough understanding of the pharmacological management of hypertension in pregnancy to ensure the safety and well-being of both the mother and the developing fetus. Choosing the appropriate antihypertensive medication, such as methyldopa in this case, requires considering the potential risks and benefits associated with each medication and following evidence-based guidelines to optimize maternal and fetal outcomes.
Option A) Candesartan and option B) Lisinopril are contraindicated in pregnancy as they belong to the category of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), which are known to cause harm to the developing fetus, especially in the second and third trimesters. These medications can lead to fetal renal impairment, hypotension, skull hypoplasia, and even death.
Option D) Furosemide is a diuretic commonly used to treat hypertension, but it is not the first-line choice for managing hypertension in pregnancy. Diuretics like furosemide can cause electrolyte imbalances and reduce placental perfusion, potentially harming the fetus.
In an educational context, it is crucial for healthcare providers to have a thorough understanding of the pharmacological management of hypertension in pregnancy to ensure the safety and well-being of both the mother and the developing fetus. Choosing the appropriate antihypertensive medication, such as methyldopa in this case, requires considering the potential risks and benefits associated with each medication and following evidence-based guidelines to optimize maternal and fetal outcomes.